Laura Biganzoli
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies 89
- Cancer Genomics and Diagnostics 15
- Oncology top 0.5%
- Cancer Treatment and Pharmacology 93
- HER2/EGFR in Cancer Research 55
- Colorectal Cancer Treatments and Studies 18
- Geriatrics and Gerontology top 1%
-
- Advanced Breast Cancer Therapies 46
-
- Recycling and Waste Management Techniques 15
-
- Metabolomics and Mass Spectrometry Studies 15
- Co-authors
- Wederson M. ClaudinoAngelo Di LeoMartine PiccartMario GrossoMatti AaproLucia RigamontiRobert ParidaensMarta Pestrin
- Journals
- Journal of Clinical Oncology (24 papers)European Journal of Cancer (22 papers)Annals of Oncology (21 papers)
- Partner nations
- ItalyBelgiumUnited Kingdom
In The Last Decade
Laura Biganzoli
216 papers receiving 7.5k citations
Hit Papers
Peers
Comparison fields: 5 of 174
- Cancer Research 2.6k
- Oncology 4.4k
- Geriatrics and Gerontology 364
- Pulmonary and Respiratory Medicine 1.6k
- Industrial and Manufacturing Engineering 300
Countries citing papers authored by Laura Biganzoli
This map shows the geographic impact of Laura Biganzoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Biganzoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Biganzoli more than expected).
Fields of papers citing papers by Laura Biganzoli
This network shows the impact of papers produced by Laura Biganzoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Biganzoli. The network helps show where Laura Biganzoli may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Laura Biganzoli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Trastuzumab deruxtecan (T-DXd) vs physician’s choice of chemotherapy (TPC) in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2 (HER2)-low or HER2-ultralow metastatic breast cancer (mBC) with prior endocrine therapy (ET): Primary results from DESTINY-Breast06 (DB-06).breakdown → | 2024 | 52 |
| 2 | 2024 | 19 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 7 | |
| 7 | 2022 | 10 | |
| 8 | 2021 | 28 | |
| 9 | 2021 | 8 | |
| 10 | 2021 | 3 | |
| 11 | 2020 | 37 | |
| 12 | 2020 | 21 | |
| 13 | 2019 | 14 | |
| 14 | 2019 | 43 | |
| 15 | 2018 | 10 | |
| 16 | Phase Ib/II study evaluating safety and efficacy of Pembrolizumab and Trastuzumab in patients with Trastuzumab-resistant HER2-positive advanced breast cancer : results from the PANACEA study (IBCSG 45-13/BIG 4-13/KEYNOTE-014) | 2017 | 5 |
| 17 | 2016 | 1 | |
| 18 | 2012 | 36 | |
| 19 | Clinical outcome of breast cancer patients with liver metastases in the anthracycline-taxane era | 2002 | 1 |
| 20 | AT (doxorubicin-Taxol) versus AC (doxorubicin-cyclophosphamide) as first line chemotherapy in metastatic breast cancer (MBC): A phase III study. (originally presented at ASCO 2000. Abstract 282) | 2000 | 13 |
About Laura Biganzoli
Laura Biganzoli is a scholar working on Cancer Research, Oncology, Geriatrics and Gerontology, Pulmonary and Respiratory Medicine and Industrial and Manufacturing Engineering, having authored 226 papers that have together received 7.7k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (93 papers), Breast Cancer Treatment Studies (89 papers), HER2/EGFR in Cancer Research (55 papers), Advanced Breast Cancer Therapies (46 papers), Colorectal Cancer Treatments and Studies (18 papers), Metabolomics and Mass Spectrometry Studies (15 papers), Cancer Genomics and Diagnostics (15 papers) and Recycling and Waste Management Techniques (15 papers). The work is most often cited by research in Cancer Research (2.6k citations), Oncology (4.4k citations), Geriatrics and Gerontology (364 citations), Pulmonary and Respiratory Medicine (1.6k citations) and Industrial and Manufacturing Engineering (300 citations). Laura Biganzoli has collaborated with scholars based in Italy, Belgium and United Kingdom. Frequent co-authors include Wederson M. Claudino, Angelo Di Leo, Martine Piccart, Mario Grosso, Matti Aapro, Lucia Rigamonti, Robert Paridaens, Marta Pestrin, Robert E. Coleman and Catherine Oakman. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, The Breast and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.